Homepage
Author:
Nautilus Biotechnology Inc.
Posted Date:
April 29, 2026
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
Nautilus Biotechnology Inc.
April 29, 2026
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
Nautilus Biotechnology Inc.
April 9, 2026
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference
Nautilus Biotechnology Inc.
March 24, 2026
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
Nautilus Biotechnology Inc.
March 18, 2026
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Nautilus Biotechnology Inc.
March 2, 2026
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
Nautilus Biotechnology Inc.
February 24, 2026
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
Nautilus Biotechnology Inc.
February 19, 2026
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Nautilus Biotechnology Inc.
February 7, 2026
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
Nautilus Biotechnology Inc.
January 28, 2026
